{"organizations": [], "uuid": "6a3b28fe29375bba8f7632b7add482a44c06f753", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180222.html", "section_title": "Archive News &amp; Video for Thursday, 22 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shield-therapeutics-sees-2017-reve/brief-shield-therapeutics-sees-2017-revenue-to-be-637000-idUSFWN1QC02O", "country": "US", "domain_rank": 408, "title": "BRIEF-Shield Therapeutics Sees 2017 Revenue To Be £637,000 ​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.5, "site_type": "news", "published": "2018-02-22T15:36:00.000+02:00", "replies_count": 0, "uuid": "6a3b28fe29375bba8f7632b7add482a44c06f753"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shield-therapeutics-sees-2017-reve/brief-shield-therapeutics-sees-2017-revenue-to-be-637000-idUSFWN1QC02O", "ord_in_thread": 0, "title": "BRIEF-Shield Therapeutics Sees 2017 Revenue To Be £637,000 ​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - Shield Therapeutics Plc:\n* ‍REVENUES FOR YEAR ENDED 31 DECEMBER 2017 EXPECTED TO BE £637,000 (2016: £304,000)​ Source text for Eikon: [ID: nFWN1QC02O] Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-22T15:36:00.000+02:00", "crawled": "2018-02-23T15:30:30.000+02:00", "highlightTitle": ""}